NCT01307267 2020-03-17A Study Of PF-05082566 As A Single Agent And In Combination With RituximabPfizerPhase 1 Completed190 enrolled 65 charts
NCT01032122 2013-04-25Rituximab in Metastatic MelanomaMedical University of ViennaPhase 1 Terminated9 enrolled